SHANGHAI BENEMAE PHARMACEUTICAL CORP has a total of 39 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are NORDIC NANOVECTOR ASA, ADC THERAPEUTICS S RL and IMUNAMI LABORATORIES PTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 5 | |
#4 | Brazil | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | United States | 3 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Hong Kong | 1 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Specific use of cosmetics | |
#5 | Microorganisms | |
#6 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Zuo Yajun | 17 |
#2 | Yu Gang | 14 |
#3 | Liu Xiaowu | 9 |
#4 | Yu Quan | 9 |
#5 | Wang Wenyi | 9 |
#6 | Qian Lifen | 7 |
#7 | Wang Shichuang | 7 |
#8 | Xia Jing | 7 |
#9 | Yu Zhiwen | 7 |
#10 | Xiong Chunlin | 6 |
Publication | Filing date | Title |
---|---|---|
US2020024362A1 | Anti-coagulation factor xi antibody | |
AU2018436195A1 | Anti-factor XI antibodies | |
CN110237239A | For treating the GLP-1 composition of fat and Weight management | |
MX2019009500A | Anti-coagulation factor xi antibody. | |
AU2002313869B2 | A method of producing glucagon-like peptide 1(GLP-1)7-36 and an GLP-1 analogue | |
AU2002257498B2 | A frog skin antibacterial peptide derivative |